Recently it has been shown that chloroacetaldehyde reacts with derivatives of adenine and cytosine to form fluorescent products1. For our study 1,N6-ethenoadenosine S^S^monophosphate (S^S'-cyclic eAMP) was prepared under conditions earlier de scribed 2. Homogeneity of product was verified by chromatography on thin layer of silicagel (Merck, Germany) with n-butanol, CH3COOH and H 20 (5:2:3, v/v/v).
The numeration of 2 follows according to the nomenclature based on the ring system, 3-/3-D-ribofuranosyl-imidazo-(2,1 -i) purine S^S^monophos-phate.
S^S'-cyclic AMP was obtained from Boehringer (Mannheim, Germany), (3H)-S^S'-cyclic AMP from NEN-Chemicals (USA), monochloroacetaldehyde from Fluka (Switzerland). Ultraviolet spectra were obtained on Acta V (Beckman) spectrometer, fluores cence spectra on Zeiss fluorescence spectrometer PM Q II with ZFM 4. The NMR-spectra were obtain ed on Bruker 90 MHz spectrometer with spectra accumulation (Fourier-transformation-impulsspectra) in D 20, pD adjusted to 6.0 with NaOD, and sodium 3-trimethyl-silylpropionate as internal stan- dard. Mass spectra were obtained by CH 5 (Varian) at 70 eY.
The NMR-spectrum of 3,,5/-cyclic fiAMP exhibits a characteristic pair of doublets at < 5 7.9 ppm (H-7) and d 7.5 ppm (H-8) with a spin-coupling constant / 7(g = 2 Hz. In contrast to the NMR-spectrum of 3 ',5 -cyclic AMP, where the protons H -8 and H-2 of purine ring give peaks at < 5 8.16 ppm and d 8.13 ppm in form of two adjacent singlets, in the spectrum of S^S -cyclic eAMP a specific deshielding effect of the This peak (m/e 135) is absent from the mass-spec trum of 3,,5/-cyclic fAM P (2). In the mass-spectrum of 2 a new peak (m/e 159) of very high intensity can be seen, corresponding to the following frag mentation:
m/e 159 C 7 H 5 N5
In both cases the formation of these fragments may well occur by a " one-event" fragmentation of 3',5 -cyclic AMP and S^S^-cyclic eAMP.
In the ultraviolet spectrum (Fig. 3 ) a character istic red shift of the spectrum of 3/,5/-cyclic eAMP can be seen in contrast to 3 ,5 -cyclic AMP and in addition it displays great differences in acidic, neu tral and basic solution.
In comparison with other reported spectra of £ analogs3 our UV-Spectra exhibit additionally two isosbestic points at 242 nm and 221 nm and a strong maximum at 225 nm. The fluorescence emission spectrum of S^S'-cyclic fAMP shows the same characteristics as the other £ analogs. £ Adenine derivatives can't be distingished by this matter. S'^'-cyclic eAMP displays an intense fluorescent emission (/max 413 nm) upon excitation at / max 314 nm. This allows ready detection at very low concentration in the range at 10 nM and the presence of the long wavelength absorption of 314 nm is im portant, because it permits excitation of the fluorophore without interference from other ultraviolet absorbing moieties in proteins and nucleic acids. In view of all these favorable fluorescence properties nM we examined especially the extent of biological activity to which it can replace the natural cyclic nucleotide as enzymatic modifier. This was tested by binding to the protein kinase system of beef adrenal under conditions described earlier for other cyclic nucleotides 4. Affinity of S^S'-cyclic ^AMP to binding protein was found to lie in the same range as the constants published for 3/,5,-cyclic A M P 4' 5. From other investigations4 > 6 it may be assumed that free-NH* at position 6 of purine ring is not decisively requir ed for binding of S^S^cyclic AMP. The result pre sented here gives additional support to this assump tion, since this site is concealed in S^S^cyclic eAMP.
The fluorescence properties of S'^-cyclic eAMP in conjunction with full biological activity as re ported here and elsewhere3 make it to a valuable tool in the field of cyclic nucleotide research.
